A case of lysozyme-induced nephropathy with improved renal function following treatment for chronic myelomonocytic leukemia. [PDF]
Nukui N +6 more
europepmc +1 more source
Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II study. [PDF]
Ma L +18 more
europepmc +1 more source
Case Report: Chronic myelomonocytic leukemia with mature plasmacytoid dendritic cell proliferation initially classified as MDS-IB2. [PDF]
Chen J, Liu J, Ren Y.
europepmc +1 more source
Case Report: Coexistence of advanced systemic mastocytosis, chronic myelomonocytic Leukemia, and t(11;14)-positive plasma-cell neoplasm: a rare triple-clonal hematologic case. [PDF]
Yin J +6 more
europepmc +1 more source
Systemic Metabolic Changes in Plasma of Patients with Myelodysplastic Neoplasms and Chronic Myelomonocytic Leukemia. [PDF]
Balaian E +14 more
europepmc +1 more source
Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification. [PDF]
Loghavi S, Hasserjian RP.
europepmc +1 more source
A phase 1b/2 study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML. [PDF]
Brunner AM +19 more
europepmc +1 more source
<i>TCL1A</i> polymorphism predicts AML progression in myeloid neoplasms. [PDF]
Molina A +6 more
europepmc +1 more source
Should flow cytometry be required for CMML diagnosis? Position of the ELN iMDS Flow Working Group. [PDF]
Wagner-Ballon O +4 more
europepmc +1 more source
KIT mutation and AHN-associated oncogenic profiles in systemic mastocytosis with an associated hematological neoplasm. [PDF]
Navarro-Navarro P +20 more
europepmc +1 more source

